Home › Coronary Artery Disease › New Mexico
Coronary Artery Disease clinical trials in New Mexico
4 studies for Coronary Artery Disease are looking for participants at sites in New Mexico.
Cities in New Mexico
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Presbyterian Heart Group, Albuquerque
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- U.S. Renal Care - Gallup, Gallup
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Product Surveillance Registry
- Albuquerque
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- New Mexico VA Health Care System, Albuquerque, NM, Albuquerque
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.